Doximity, Inc. $DOCS Holdings Lifted by Y Intercept Hong Kong Ltd

Posted by Stanley Muller on Jul 5th, 2026

Y Intercept Hong Kong Ltd raised its position in Doximity, Inc. (NYSE:DOCS – Free Report) by 40.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 284,368 shares of the company’s stock after purchasing an additional 81,186 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Doximity were worth $6,626,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in DOCS. Royal Bank of Canada grew its holdings in Doximity by 24.2% in the 1st quarter. Royal Bank of Canada now owns 106,845 shares of the company’s stock worth $6,200,000 after buying an additional 20,847 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after acquiring an additional 210 shares in the last quarter. NewEdge Advisors LLC raised its stake in Doximity by 613.7% during the 1st quarter. NewEdge Advisors LLC now owns 6,323 shares of the company’s stock valued at $367,000 after acquiring an additional 5,437 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Doximity by 33.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 255,529 shares of the company’s stock worth $14,828,000 after acquiring an additional 63,873 shares during the period. Finally, Focus Partners Wealth acquired a new position in Doximity during the 1st quarter worth $283,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Buying and Selling

In related news, insider Siddharth Sitaram sold 2,444 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the sale, the insider directly owned 90,706 shares in the company, valued at approximately $1,851,309.46. This trade represents a 2.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $26.06, for a total value of $234,540.00. Following the completion of the transaction, the director directly owned 19,839 shares in the company, valued at $517,004.34. This represents a 31.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 16,180 shares of company stock valued at $395,110 over the last 90 days. 31.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Mizuho decreased their price target on Doximity from $34.00 to $26.00 and set a “neutral” rating for the company in a research note on Thursday, May 14th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $44.00 price objective on shares of Doximity in a report on Monday, March 9th. Barclays reiterated an “equal weight” rating and issued a $20.00 target price (down from $38.00) on shares of Doximity in a research report on Thursday, May 14th. Weiss Ratings cut shares of Doximity from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 15th. Finally, Loop Capital set a $31.00 target price on shares of Doximity in a research note on Tuesday, March 17th. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $29.33.

View Our Latest Report on Doximity

Doximity Trading Up 0.0%

Shares of NYSE DOCS opened at $21.86 on Friday. Doximity, Inc. has a twelve month low of $17.15 and a twelve month high of $76.51. The firm has a 50-day moving average of $21.62 and a two-hundred day moving average of $28.20. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 22.09, a PEG ratio of 6.79 and a beta of 1.30.

About Doximity

(Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.